The Latest Breaking News from VRBPAC

One Historic Week for Flu: Generic Xofluza Approved June 17, mRNA Flu Vaccine VRBPAC Vote June 18 — Here's What Both Mean for 2026–27

FDA approved generic baloxavir June 17; VRBPAC voted on mRNA flu vaccine June 18. The 2025–26 flu season killed 24,000 Americans. Here's what both mean for 2026–27.

Medical Daily · Jun 20

FDA Advisory Panel Votes Today on First mRNA Flu Vaccine as MFLUSIVA Phase 3 Results Face Intense Scrutiny

FDA VRBPAC votes June 18 on Moderna's MFLUSIVA — the first mRNA flu vaccine. Phase 3 showed 26.6% RVE vs. standard dose; 47.9% vs. healthcare outcomes. PDUFA August 5, 2026.

Medical Daily · Jun 18

RFK Jr critic Paul Offit removed from FDA vaccine advisory committee

Offit, long-serving vaccine scientist, says he was not given a reason for dismissal after initially being offered extension

The Guardian - US · Sep 2, 2025

FDA Sets Review Dates For Pfizer, Moderna COVID-19 Shot For Kids, Plus Novavax EUA

The FDA has set up June meeting dates to review COVID-19 vaccine submissions, noting that the dates are tentative as none of the submissions are complete.   The agency reserved June 8, 21, and 22 for virtual meetings of the Vaccines and Related Biological Products Advisory Committee (VRBPAC) to review Moderna Inc (NASDAQ: MRNA) and Pfizer Inc (NYSE: PFE)…

Benzinga · Apr 29, 2022

FDA approves second shot for 50+

The authorization for another booster arrives just as BA.2 becomes the dominant strain in the U.S.

Salon · Mar 30, 2022